SCHEMBL4283767

SCHEMBL4283767

CN(CCN1CCCCC1)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.56
SIGMAR1 Q99720 5/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
EGFR P00533 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
NPY1R P25929 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19717823 0.87 HRH3 (0.46) HRH3SIGMAR1
SCHEMBL17191998 0.85 SIGMAR1 (0.50) HRH3SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL27482008 0.85 ALDH1A1 (0.51) HRH3SIGMAR1KDM4EALDH1A1
SCHEMBL13661448 0.84 SIGMAR1 (0.46) HRH3SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL13661596 0.83 SIGMAR1 (0.46) HRH3SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL23291276 0.82 HTT (0.61) HRH3NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL21120476 0.82 SMN1; SMN2 (0.55) HRH3SIGMAR1NPC1RAB9ASMN1; SMN2
SCHEMBL19717423 0.81 MEN1 (0.46) SIGMAR1
SCHEMBL7367495 0.81 ALDH1A1 (0.58) SIGMAR1ALDH1A1
SCHEMBL4274572 0.81 CCR5 (0.50) HRH3SIGMAR1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131246-A1 SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS ASTELLAS PHARMA INC. (JP) 2009-10-29 WO disclosed
WO-2009131246-A1 SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS ASTELLAS PHARMA INC. (JP) 2009-10-29 WO disclosed